ALXN
Alexion Pharmaceuticals, Inc.
EVP, Global Head of R, D Martin Mackay sold $139K of Alexion Pharmaceuticals, Inc.
Sold$138,910
$138.91Price
1,000Shares
−2%Stake
What ALXN did after the filing
Prices for ALXN after this filing aren't in yet.
Traded Mon, Feb 29. Filed Tue, Mar 1, 6:34 PM ET, after the close. Not investment advice.